Respostas Clínicas Cochrane
As Respostas Clínicas Cochrane (RCCs) proporcionam um ponto de entrada amigável, digerível e clinicamente focado para as pesquisas rigorosas das revisões sistemáticas Cochrane. Elas são desenvolvidas para serem acionáveis e para respaldar a tomada de decisão no local de atendimento, e foram adicionadas a seções relevantes do texto principal do Best Practice.
- Is there randomized controlled trial evidence to support the use of antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals?
- For sexually active women, do topical microbicides prevent sexually transmitted infections (STIs)?
- Does antiretroviral therapy prevent HIV transmission in HIV-discordant couples?
- Can circumcision in men prevent homosexual acquisition of HIV?
- What are the effects of antiretroviral resistance testing for people with HIV?
- Can prospective genetic testing be used to prevent hypersensitivity reactions to drug treatment in adults with HIV type 1?
- How does family planning (with or without HIV prevention) compare with usual care for women living with HIV?
- In severely immunodepressed people, how does fluconazole compare with nystatin for improving outcomes?
- What are the effects of multiple micronutrient supplementation for adolescents and adults with HIV infection?
- How do nutritional interventions affect outcomes in adults with HIV?
- For adults with HIV infection receiving multivitamin supplementation, how does a high dose compare with a standard dose?
- For adults with HIV infection, what are the effects of rapid initiation of antiretroviral therapy (ART)?
- What is the optimal time to initiate antiretroviral therapy in treatment-naive adults with asymptomatic HIV infection?
O uso deste conteúdo está sujeito ao nosso aviso legal